Cargando…

Enantioselectivity of chiral di­hydro­myricetin in multicomponent solid solutions regulated by subtle structural mutation

Multicomponent crystals of a chiral drug with non-chiral components have attracted increasing attention in the application of enantiomer purification and regulation of the physicochemical properties of crystalline materials. Crystalline solid solutions provide opportunities for fine-tuning material...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Jie, Wang, Yaoguo, Tang, Weiwei, Gong, Junbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Union of Crystallography 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980384/
https://www.ncbi.nlm.nih.gov/pubmed/36692859
http://dx.doi.org/10.1107/S2052252523000118
_version_ 1784899904579043328
author Sun, Jie
Wang, Yaoguo
Tang, Weiwei
Gong, Junbo
author_facet Sun, Jie
Wang, Yaoguo
Tang, Weiwei
Gong, Junbo
author_sort Sun, Jie
collection PubMed
description Multicomponent crystals of a chiral drug with non-chiral components have attracted increasing attention in the application of enantiomer purification and regulation of the physicochemical properties of crystalline materials. Crystalline solid solutions provide opportunities for fine-tuning material properties because of continuously adjustable component stoichiometry ratios. The synthesis, crystal structure, thermodynamics and solid-state enantioselectivity of a series of multicomponent crystals of chiral di­hydro­myricetin (DMY) with caffeine (CAF) or theophylline (THE) were investigated and the results reveal how the subtle change of molecular structure of the coformer dictates the enantiomer selectivity in multicomponent cocrystals. A series of multicomponent cocrystal solvates of chiral DMY with CAF and THE were synthesized by the slurry cocrystallization method in aceto­nitrile. Although most racemic mixtures crystallize as racemic compounds or conglomerates, both DMY–CAF and DMY–THE crystallize as chiral solid solutions, unveiled by pseudo-binary melt phase diagrams and pseudo-ternary solution phase diagrams. Crystal structures of Rac-DMY–CAF, R,R-DMY–CAF, Rac-DMY–THE and R,R-DMY–THE are reported for the first time via single-crystal X-ray diffraction, displaying two distinct types of solid solution differing in mixing scale of enantiomers spanning several orders of magnitude. Surprisingly, this remarkable impact on enantiomer discrimination was simply achieved by the reduction of a methyl group of CAF to the THE coformer, which was further rationalized from their crystal structures and intermolecular interactions. Collectively, this work has demonstrated that a subtle change in the molecular structure of a coformer can regulate enantioselectivity in crystalline materials, guiding the purification of chiral racemic compounds via the cocrystallization method and the design of solid-solution crystalline materials.
format Online
Article
Text
id pubmed-9980384
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher International Union of Crystallography
record_format MEDLINE/PubMed
spelling pubmed-99803842023-03-03 Enantioselectivity of chiral di­hydro­myricetin in multicomponent solid solutions regulated by subtle structural mutation Sun, Jie Wang, Yaoguo Tang, Weiwei Gong, Junbo IUCrJ Research Papers Multicomponent crystals of a chiral drug with non-chiral components have attracted increasing attention in the application of enantiomer purification and regulation of the physicochemical properties of crystalline materials. Crystalline solid solutions provide opportunities for fine-tuning material properties because of continuously adjustable component stoichiometry ratios. The synthesis, crystal structure, thermodynamics and solid-state enantioselectivity of a series of multicomponent crystals of chiral di­hydro­myricetin (DMY) with caffeine (CAF) or theophylline (THE) were investigated and the results reveal how the subtle change of molecular structure of the coformer dictates the enantiomer selectivity in multicomponent cocrystals. A series of multicomponent cocrystal solvates of chiral DMY with CAF and THE were synthesized by the slurry cocrystallization method in aceto­nitrile. Although most racemic mixtures crystallize as racemic compounds or conglomerates, both DMY–CAF and DMY–THE crystallize as chiral solid solutions, unveiled by pseudo-binary melt phase diagrams and pseudo-ternary solution phase diagrams. Crystal structures of Rac-DMY–CAF, R,R-DMY–CAF, Rac-DMY–THE and R,R-DMY–THE are reported for the first time via single-crystal X-ray diffraction, displaying two distinct types of solid solution differing in mixing scale of enantiomers spanning several orders of magnitude. Surprisingly, this remarkable impact on enantiomer discrimination was simply achieved by the reduction of a methyl group of CAF to the THE coformer, which was further rationalized from their crystal structures and intermolecular interactions. Collectively, this work has demonstrated that a subtle change in the molecular structure of a coformer can regulate enantioselectivity in crystalline materials, guiding the purification of chiral racemic compounds via the cocrystallization method and the design of solid-solution crystalline materials. International Union of Crystallography 2023-01-21 /pmc/articles/PMC9980384/ /pubmed/36692859 http://dx.doi.org/10.1107/S2052252523000118 Text en © Jie Sun et al. 2023 https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.
spellingShingle Research Papers
Sun, Jie
Wang, Yaoguo
Tang, Weiwei
Gong, Junbo
Enantioselectivity of chiral di­hydro­myricetin in multicomponent solid solutions regulated by subtle structural mutation
title Enantioselectivity of chiral di­hydro­myricetin in multicomponent solid solutions regulated by subtle structural mutation
title_full Enantioselectivity of chiral di­hydro­myricetin in multicomponent solid solutions regulated by subtle structural mutation
title_fullStr Enantioselectivity of chiral di­hydro­myricetin in multicomponent solid solutions regulated by subtle structural mutation
title_full_unstemmed Enantioselectivity of chiral di­hydro­myricetin in multicomponent solid solutions regulated by subtle structural mutation
title_short Enantioselectivity of chiral di­hydro­myricetin in multicomponent solid solutions regulated by subtle structural mutation
title_sort enantioselectivity of chiral di­hydro­myricetin in multicomponent solid solutions regulated by subtle structural mutation
topic Research Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980384/
https://www.ncbi.nlm.nih.gov/pubmed/36692859
http://dx.doi.org/10.1107/S2052252523000118
work_keys_str_mv AT sunjie enantioselectivityofchiraldihydromyricetininmulticomponentsolidsolutionsregulatedbysubtlestructuralmutation
AT wangyaoguo enantioselectivityofchiraldihydromyricetininmulticomponentsolidsolutionsregulatedbysubtlestructuralmutation
AT tangweiwei enantioselectivityofchiraldihydromyricetininmulticomponentsolidsolutionsregulatedbysubtlestructuralmutation
AT gongjunbo enantioselectivityofchiraldihydromyricetininmulticomponentsolidsolutionsregulatedbysubtlestructuralmutation